Analysis of LRRK2 Gly2385Arg genetic variant in non-Chinese Asians

Movement Disorders

Volumn 22, Issue 12, 2007, Pages 1816-1818

  Tan, Eng King ^a,b,c   Zhao, Yi ^a   Tan, Louis ^b   Lim, Hui Qin ^a   Lee, Jasinda ^a   Yuen, Yih ^a   Pavanni, Ratnagopal ^a,c   Wong, Meng Cheong ^a,c   Fook Chong, Stephanie ^a   Liu, Jian Jun ^d  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^c Singapore Health Services   (Singapore)

^d GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

LRRK2; Mutation; Parkinson's disease

Indexed keywords

ARGININE; DNA; GLYCINE; LEUCINE RICH REPEAT KINASE 2;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; ASIAN; CONTROLLED STUDY; DNA ISOLATION; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; SINGAPORE; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; ARGININE; ASIA, SOUTHEASTERN; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENOTYPE; GLYCINE; HUMANS; INDIA; MALE; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS;

EID: 35348968375     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21658     Document Type: Article

References (24)

1. Tan EK, Jankovic J. Genetic testing in Parkinson disease: promises and pitfalls. Arch Neurol 2006;63:1232-1237.
2. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-607.
3. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44:595-600.
4. Skipper L, Shen H, Chua E, et al. Analysis of LRRK2 functional domains in nondominant Parkinson disease. Neurology 2005;65: 1319-1321.
5. Di Fonzo A, Rohe CF, Ferreira J, et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 2005;365:412-415.
6. Gilks WP, Abou-Sleiman PM, Gandhi S, et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005;365:415-416.
7. Kachergus J, Mata IF, Hulihan M, et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 2005;76:672-680.
8. Lesage S, Durr A, Tazir M, et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 2006; 354:422-423.
9. Ozelius LJ, Senthil G, Saunders-Pullman R, et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 2006;354:424-425.
10. Lesage S, Leutenegger A-L, Ibanez P, et al. LRRK2 haplotype analyses in European and North African families with Parkinson's disease: a common founder for the G2019S mutation dating from the 13th century. Am J Hum Genet 2005;77:330-332.
11. Tan EK, Shen H, Tan LC, et al. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neurosci Lett 2005;384:327-329.
12. Lu CS, Simons EJ, Wu-Chou YH, et al. The LRRK2 12012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease. Parkinsonism Relat Disord 2005;11: 521-522.
13. Fung HC, Chen CM, Hardy J, Hernandez D, Singleton A, Wu YR. Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease. Mov Disord 2006;21:880-881.
14. Mata IF, Kachergus JM, Taylor JP, et al. LRRK2 pathogenic substitutions in Parkinson's disease. Neurogenetics 2005;6:171-177.
15. Di Fonzo A, Wu-Chou YH, Lu CS, et al. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 2006;7:133-138.
16. Tan EK, Zhao Y, Skipper L, et al. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum Genet 2007;120:857-863.
17. Fung HC, Chen CM, Hardy J, Singleton AB, Wu YR. A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan. BMC Neurol 2006;6:47.
18. Farrer MJ, Stone JT, Lin CH, et al. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat Disord 2007;13:89-92.
19. Funayama M, Y Li, Yoshino H, et al. A variation in LRRK2 is associated with Parkinson's disease in Asian population. Neuroreport 2007;18:273-275.
20. Di Fonzo A, Tassorelli C, De Mari M, et al. Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet 2006;14:322-331.
21. Tan LC, Venketasubramanian N, Hong CY, et al. Prevalence of Parkinson disease in Singapore: Chinese vs. Malays vs. Indians. Neurology 2004;62:1999-2004.
22. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
23. Tan EK, Skipper L, Chua E, et al. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease. Mov Disord 2006;21:997-1001.
24. Zhao Y, Tan EK, Law HY, Yoon CS, Wong MC, Ng I. Prevalence and ethnic differences of autosomal-dominant cerebellar ataxia in Singapore. Clin Genet 2002;62:478-481.